Abeona Therapeutics Inc. (ABEO) financial statements (2020 and earlier)

Company profile

Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR
NEW YORK, NY 10019
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:129851386940120
Cash and cash equivalents129191386940120
Short-term investments 66     
Other undisclosed cash, cash equivalents, and short-term investments 0     
Receivables 000000
Prepaid expense and other current assets0
Other undisclosed current assets34300  
Total current assets:132891416941121
Noncurrent Assets
Operating lease, right-of-use asset8
Property, plant and equipment13911000
Intangible assets, net (including goodwill)69763641395
Goodwill3232323232  
Intangible assets, net (excluding goodwill)36434875 
Other undisclosed noncurrent assets1100000
Total noncurrent assets:918638423950
TOTAL ASSETS:22317417911180171
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities91024122
Accounts payable4624121
Accrued liabilities64    1
Deferred revenue0
Debt2    0 
Due to related parties27      
Deferred revenue and credits31111
Other undisclosed current liabilities 10 4  7
Total current liabilities:392068139
Noncurrent Liabilities
Long-term debt and lease obligation6      
Operating lease, liability6
Liabilities, other than long-term debt  34755
Deferred revenue and credits34455
Business combination, contingent consideration, liability    3 
Other undisclosed noncurrent liabilities 20  441
Total noncurrent liabilities:620341196
Total liabilities:4540912121215
Stockholders' equity
Stockholders' equity attributable to parent17813417099685(15)
Common stock1000000
Treasury stock, value      (0)
Additional paid in capital664544529431378301251
Accumulated deficit(486)(410)(360)(332)(311)(296)(266)
Total stockholders' equity:17813417099685(15)
TOTAL LIABILITIES AND EQUITY:22317417911180171

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues 311112
Revenue, net11112
Cost of revenue (1)(1)(1)(1)(1)(0)
Cost of goods and services sold     (1)(0)
Gross profit: 2001(0)2
Operating expenses(77)(60)(28)(24)(19)(4)(6)
Other undisclosed operating income     1 
Operating loss:(77)(58)(28)(24)(19)(3)(4)
Nonoperating income (expense) 2124(24)8
Investment income, nonoperating 212400
Interest and debt expense(0)   (0)(1)(0)
Net income (loss):(77)(57)(27)(22)(15)(27)4
Other undisclosed net income (loss) attributable to parent1(0)  010
Net income (loss) attributable to parent:(76)(57)(27)(22)(15)(27)4
Preferred stock dividends and other adjustments     (3)(3)
Net income (loss) available to common stockholders, diluted:(76)(57)(27)(22)(15)(30)2

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):(77)(57)(27)(22)(15)(27)4
Comprehensive income (loss), net of tax, attributable to parent:(77)(57)(27)(22)(15)(27)4

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: